Kiniksa will now focus its development efforts on the IL-1 blocker KPL-387, which it is testing for recurrent pericarditis ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...

The CDC said in a statement on Monday that it does not believe the new coronavirus found in bats poses a concern to public health currently.

Monoclonal antibodies are a type of protein researchers make in a lab to mimic your body’s natural antibodies. Antibodies are part of your immune system. They identify substances that shouldn ...

The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...

Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease ...

Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...